Dr. Alec Salminen is a biomedical engineer whose research bridges microphysiological systems and toxicology to advance the establishment and acceptance of new approach methodologies. He earned his PhD from the University of Rochester, where his dissertation focused on developing novel in vitro models to study endothelial dysfunction and immune cell behavior during inflammation, which was honored with the University's Outstanding Dissertation Award. During his postdoctoral training at the U.S. FDA’s National Center for Toxicological Research, his research involved the evaluation of alternative skin barrier models, collaborating closely with centers across the FDA and NIH to advance our understanding of in vitro permeation testing for regulatory application. He now serves as Manager of the In Vitro Assay Services group at LifeNet Health LifeSciences, leading a team that provides comprehensive in vitro toxicology testing to industry, government, and academic partners.